Aramchol, a small molecule in the Galmed Pharmaceuticals pipeline, prevented and reversed inflammation and scarring (fibrosis) of the bile ducts in mouse models of cholestasis-related injury and fibrosis, a study showed. The bile ducts are the tubes that transport the digestive fluid bile from the liver to the intestines. Cholestasis refers to a slowed or […] The post Aramchol shows promise as PSC treatment, mouse study finds appeared first on Liver Disease News.
